DE69226432D1 - 2-spirocyclopropyl 4-acylcephalosporine und verfahren zu ihrer herstellung - Google Patents

2-spirocyclopropyl 4-acylcephalosporine und verfahren zu ihrer herstellung

Info

Publication number
DE69226432D1
DE69226432D1 DE69226432T DE69226432T DE69226432D1 DE 69226432 D1 DE69226432 D1 DE 69226432D1 DE 69226432 T DE69226432 T DE 69226432T DE 69226432 T DE69226432 T DE 69226432T DE 69226432 D1 DE69226432 D1 DE 69226432D1
Authority
DE
Germany
Prior art keywords
spirocyclopropyl
acylcephalosporine
production
useful
acylcephem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69226432T
Other languages
English (en)
Inventor
Samarendra Maiti
Narender Reddy
David Czajkowski
Paul Spevak
Charles Fiakpui
Ronald Micetich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synphar Laboratories Inc
Original Assignee
Synphar Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synphar Laboratories Inc filed Critical Synphar Laboratories Inc
Application granted granted Critical
Publication of DE69226432D1 publication Critical patent/DE69226432D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69226432T 1991-04-08 1992-04-07 2-spirocyclopropyl 4-acylcephalosporine und verfahren zu ihrer herstellung Expired - Lifetime DE69226432D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/681,680 US5258377A (en) 1991-04-08 1991-04-08 2-spirocyclopropyl 4-acylcephems
PCT/CA1992/000145 WO1992017482A1 (en) 1991-04-08 1992-04-07 Novel 2-spirocyclopropyl 4-acylcephems and processes for the preparation thereof

Publications (1)

Publication Number Publication Date
DE69226432D1 true DE69226432D1 (de) 1998-09-03

Family

ID=24736298

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69226432T Expired - Lifetime DE69226432D1 (de) 1991-04-08 1992-04-07 2-spirocyclopropyl 4-acylcephalosporine und verfahren zu ihrer herstellung

Country Status (10)

Country Link
US (1) US5258377A (de)
EP (1) EP0580650B1 (de)
JP (1) JPH06506207A (de)
AT (1) ATE169023T1 (de)
CA (1) CA2107892A1 (de)
DE (1) DE69226432D1 (de)
FI (1) FI934395A (de)
HU (1) HUT66046A (de)
WO (1) WO1992017482A1 (de)
ZA (1) ZA922504B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8811388D0 (en) * 1988-05-13 1988-06-15 Erba Carlo Spa 1,1-dioxo-cephem-4-carbothiolic acid derivatives
GB8928373D0 (en) * 1989-12-15 1990-02-21 Erba Carlo Spa Beta-lactam derivatives
US5439904A (en) * 1993-12-07 1995-08-08 Synphar Laboratories, Inc. 2-spiro(2'-spirocycloalkyl)cyclopropyl cephalosporin sulfones as antiinflammatory and antigenerative agents
US5597817A (en) * 1994-12-09 1997-01-28 Southern Methodist University 7-vinylidene cephalosporins and methods of using the same
US5629306A (en) 1994-12-09 1997-05-13 Research Corporation Technologies, Inc. 7-alkylidene cephalosporanic acid derivatives and methods of using the same
US5760027A (en) * 1996-12-06 1998-06-02 Research Corporation Technologies, Inc. Use of 7-alkylidene cephalosporins to inhibit elastase activity
US6407091B1 (en) * 1999-04-15 2002-06-18 Research Corporation Technologies, Inc. β-lactamase inhibiting compounds
EP1660506A4 (de) * 2003-08-25 2009-02-25 Revaax Pharmaceuticals Llc Orale neurotherapeutische cefazolinzusammensetzungen
WO2019038412A1 (en) 2017-08-24 2019-02-28 Novo Nordisk A/S GLP-1 COMPOSITIONS AND USES THEREOF
BR112022013746A2 (pt) 2020-02-18 2022-10-11 Novo Nordisk As Formulação aquosa de cagrilintida, formulação aquosa de semaglutida, dispositivo médico, e, combinação de dose fixa

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH563396A5 (de) * 1970-06-05 1975-06-30 Ciba Geigy Ag
US4547371A (en) * 1983-04-18 1985-10-15 Merck & Co., Inc. Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
EP0124081A3 (de) * 1983-05-02 1986-11-26 Merck & Co. Inc. Substituierte Cephalosporinsulfone mit Antientzündungs- und Antidegenerativwirkung, sie enthaltende Zusammensetzungen und Verfahren zur Herstellung
US4717722A (en) * 1984-05-07 1988-01-05 Merck & Co., Inc. Substituted 1-oxa-dethiacephalosporins as anti-inflammatory and antidegenerative agents
EP0267723B1 (de) * 1986-11-12 1996-02-07 Merck & Co. Inc. Substituierte Cephalosporinsulfone als anti-entzündliche und anti-degenerative Mittel
JPH01226887A (ja) * 1988-03-07 1989-09-11 Takeda Chem Ind Ltd ３環性セファムまたはイソセファム化合物，その製造法およびエラスターゼ阻害剤
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
GB8811388D0 (en) * 1988-05-13 1988-06-15 Erba Carlo Spa 1,1-dioxo-cephem-4-carbothiolic acid derivatives
JPH05503290A (ja) * 1989-10-06 1993-06-03 シンファー　ラボラトリーズ，インコーポレーティッド 新規２―スピロシクロプロピルセファロスポリンスルホン誘導体およびそれらの製造法

Also Published As

Publication number Publication date
HUT66046A (en) 1994-09-28
US5258377A (en) 1993-11-02
AU668503B2 (en) 1996-05-09
EP0580650B1 (de) 1998-07-29
JPH06506207A (ja) 1994-07-14
ZA922504B (en) 1993-12-07
EP0580650A1 (de) 1994-02-02
AU1556092A (en) 1992-11-02
ATE169023T1 (de) 1998-08-15
FI934395A0 (fi) 1993-10-06
WO1992017482A1 (en) 1992-10-15
HU9302717D0 (en) 1993-12-28
FI934395A (fi) 1993-10-21
CA2107892A1 (en) 1992-10-09

Similar Documents

Publication Publication Date Title
DK0624596T3 (da) Tetrazolderivater af galdesyrer, fremgangsmåde tilderes fremstilling og anvendelse af disse forbindelser som lægemidler
HU9301362D0 (en) Method for producing 4-aryl-piperazines and 4-aryl-piperidines
TW289020B (de)
MX9304756A (es) 9-[(glicilo substituido)amido]-6-desmetil-6-desoxitetraciclinas, metodo para su produccion y composiciones farmaceuticas que las contienen.
IS4185A (is) Hliðstæð aðferð til framleiðslu fenýlsúlfonylamino-pýrimidines afleiða
DE59410008D1 (de) Verfahren zur Herstellung von Perylen-3,4-dicarbonsäurederivaten
ATE219499T1 (de) Lipopeptid-derivate, verfahren zu ihrer herstellung und ihre verwendung
NO992929D0 (no) Salte ut fremgangsmÕte for krystallisering av 2,4,6,8,10,12-heksanitro-2,4,6,8,10,12-heksaazatetracyklo(5.5.0.05,903,11)-dodecan
ATE169023T1 (de) 2-spirocyclopropyl 4-acylcephalosporine und verfahren zu ihrer herstellung
FI101376B1 (fi) Menetelmä 3-bentsyyliamino-2-fenyylipiperidiinijohdannaisten valmistamiseksi
ATE30719T1 (de) Imino-2-pyrrolidine, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
ATE154008T1 (de) Lacton-verbindung und verfahren zu ihrer herstellung
ATE174919T1 (de) 2-spirocyclopropylcephalosporinderivate und verfahren zu ihrer herstellung
NO943765L (no) Aryloksybenzen-herbicidmidler
WO1992018474A3 (en) Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof
ATE63920T1 (de) Neue n-glycosylamidderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ATE113598T1 (de) Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE192144T1 (de) Neue pilocarpinderivate und verfahren zu ihrer herstellung
ATE18560T1 (de) Cephemderivate und verfahren zu ihrer herstellung.
ATE168110T1 (de) Verfahren und zwischenprodukte zur herstellung von 5-oxaspiro (2.4> heptan-6-on
ATE287440T1 (de) Zusammensetzungen zum entfernen von kalkstein
TH13553EX (th) กรรมวิธีที่ดีขึ้นสำหรับเตรียมเซฟาโลสพอรินส์

Legal Events

Date Code Title Description
8332 No legal effect for de